Poland – Pharmaceutical products – Sukcesywna dostawa produktów leczniczych (ruksolitynib) do realizacji niekomercyjnego badania klinicznego „Single-arm interventional study with ruxolitinib and AIEOP-BFM 2017 chemotherapy in children with acute lymphoblastic leukemia and confirmed activation of JAK/STAT pathway”
Tender Description
Sukcesywna dostawa produktów leczniczych (ruksolitynib) do realizacji niekomercyjnego badania klinicznego „Single-arm interventional study with ruxolitinib and AIEOP-BFM 2017 chemotherapy in children with acute lymphoblastic leukemia and confirmed activation of JAK/STAT pathway” Badanie kliniczne „Single-arm interventional study with ruxolitinib and AIEOP-BFM 2017 chemotherapy in children with acute lymphoblastic leukemia and confirmed activation of JAK/STAT pathway” w ramach projektu "Childhood ALL in Poland (CALL-POL) project: a national harmonization of diagnostics and treatment of acute lymphoblastic leukemia in children”
Unlock Full Tender Insight
Complete details, deadlines, and AI-powered analysis are available inside the tend.ee platform. Create your free account to access.
It's free to get started. No credit card required.